Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review.

Chambers, Duncan, Bagnall, Anne-Marie, Hempel, Susanne et al. · Journal of the Royal Society of Medicine · 2006 · DOI

Quick Summary

This review looked at 70 studies to find out which treatments help people with ME/CFS. The researchers found that two talking therapies—cognitive behaviour therapy and graded exercise therapy—showed the most promise for reducing symptoms and helping people function better. For most other treatments tested, there wasn't enough clear evidence that they worked, and some caused unwanted side effects.

Why It Matters

This comprehensive review synthesizes the largest body of intervention research available for ME/CFS, providing patients and clinicians with an evidence-based overview of treatment options. By identifying which therapies have stronger supporting evidence, it helps guide clinical decisions and informs patients about realistic expectations for symptom management and functional recovery.

Observed Findings

Graded exercise therapy and cognitive behaviour therapy showed evidence of symptom reduction and functional improvement in randomized controlled trials.
Most pharmacological, immunological, and complementary therapy interventions had inconclusive evidence of effectiveness.
Some interventions were associated with significant adverse effects.
Major heterogeneity existed across studies in diagnostic criteria, patient populations, and outcome measurement.
The quality and size of the evidence base for CFS/ME interventions increased substantially in the five years preceding this review.

Inferred Conclusions

Behavioral interventions, particularly GET and CBT, represent the most evidence-supported treatment approaches for symptom reduction and functional improvement in CFS/ME.
Most other intervention categories lack sufficient evidence of effectiveness and require further rigorous research.
Future research must identify patient characteristics that predict which individuals will benefit from specific interventions.
Clinically relevant, objective outcome measures are needed to improve comparability and interpretability of intervention trials.

Remaining Questions

Which patient characteristics (disease duration, severity, subtype, comorbidities) predict favorable response to GET, CBT, or other interventions?
Are there identifiable subgroups of ME/CFS patients for whom particular interventions are contraindicated?
What are the optimal parameters (intensity, duration, frequency) for behavioral interventions to maximize benefit while minimizing harm?
How do long-term outcomes and durability of treatment effects compare across different intervention approaches?

What This Study Does Not Prove

This systematic review does not prove that GET and CBT are universally effective for all ME/CFS patients—the evidence base is limited by heterogeneous diagnostic criteria, outcome measures, and study populations. The review cannot establish individual patient factors that predict treatment response, nor does it definitively rule out potential harms from interventions with insufficient safety data. Evidence of 'promising results' differs from proof of clinical efficacy.

Metadata

DOI: 10.1177/014107680609901012
PMID: 17021301
Evidence level: Higher-level evidence type — systematic reviews, meta-analyses, guidelines, or major syntheses (study type, not a quality guarantee)
Last updated: 12 April 2026

Explore further

Browse all studies →

About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →

Cite this study

The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.

Primary citation

Chambers, Duncan, Bagnall, Anne-Marie, Hempel, Susanne, & Forbes, Carol (2006). Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review.. Journal of the Royal Society of Medicine. https://doi.org/10.1177/014107680609901012

BibTeX

@article{mecfsatlas-chambers-2006-interventions-treatment,
  author  = {Chambers, Duncan and Bagnall, Anne-Marie and Hempel, Susanne and Forbes, Carol},
  title   = {Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review.},
  journal = {Journal of the Royal Society of Medicine},
  year    = {2006},
  doi     = {10.1177/014107680609901012},
  note    = {PubMed: 17021301},
  url     = {https://www.mecfsatlas.com/evidence/chambers-2006-interventions-treatment},
}

Atlas snapshot reference

ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-05-28. https://www.mecfsatlas.com/evidence/chambers-2006-interventions-treatment

Contribute

Private, reviewed by a human. Not a public comment thread.

Report an error Suggest a source Ask a follow-up Request a guide

Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review.

Quick Summary

Why It Matters

Observed Findings

Inferred Conclusions

Remaining Questions

What This Study Does Not Prove

Tags

Metadata

Explore further

Cite this study

Evidence Atlas

Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review.

Quick Summary

Why It Matters

Observed Findings

Inferred Conclusions

Remaining Questions

What This Study Does Not Prove

Tags

Metadata

Explore further

Cite this study